PathRed Scientific Committee

Prof Kerrigan McCarthy Prof Kerrigan McCarthy

Professor Kerrigan McCarthy is the Head of the Outbreak Response Unit and the Acting Head of the Division of Public Health, Surveillance and Response, of the National Institute for Communicable Diseases. She has a unique combination of public health, laboratory specialist, social science and clinical infectious diseases work experience within the South African public and NGO sectors. After graduating from the University of the Witwatersrand with MBBCh (1995), and obtaining a specialist qualification in Microbiology (FCPath (Micro) in 2002, she served as Head of the Mycology Unit at the National Institute of Communicable Diseases (NICD) 2002-7, where with the GERMS-SA surveillance network, she established national surveillance for cryptococcal disease, fungal susceptibility testing, and fungal molecular epidemiology. In 2007 she moved into the NGO sector to assume responsibility for TB/HIV integration in PEPFAR funded projects in the City of Johannesburg and facilitate investigator-led implementation science research agenda related to TB diagnostics, TB case-finding and INH prophylaxis. In 2011, Kerrigan moved to the Aurum Institute, as Scientist and Co-ordinator of the XTEND study - a pragmatic randomised controlled trial of Xpert vs smear for TB diagnosis in 40 clinics across 4 SA provinces. From 2005-2015, Kerrigan provided clinical service at Nazareth House, Johannesburg for persons living with HIV, including ART initiation and management of a 22-bed in-patient hospice. Kerrigan graduated with a MPhil (theology) in 2012 with a dissertation entitled ‘A theology of healing for contemporary South Africa -a phenomenological and multidisciplinary approach from the perspectives of Western medicine, African Traditional Religion and Christian theology.” Currently, as Head of the Outbreak Response Unit at the NICD, Kerrigan manages a team of persons who support national, provincial and district government with regard to outbreak investigation. She has overall responsibility for the NICD Public Health Emergency Operations Centre in accordance with the International Health Regulations.

Prof Johnny Mahlangu

Professor Johnny Mahlangu (BSc, MBBCH, FCPath, MMed, Cert Clin Haem.) is a Personal Professor of Haematology and Head of School of Pathology in the Faculty of Health Sciences of the University of the Witwatersrand and the National Health Laboratory Service in Johannesburg, South Africa. He is also Director of the International Haemophilia Training Centre and Consultant Clinical Haematologist at the Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg. Dr Mahlangu received his undergraduate and postgraduate training in science and medicine at the University of the Witwatersrand with haematology specialist and clinical haematology sub-specialist qualifications through the Colleges of Medicine. He has published many journal articles and abstracts and has delivered lectures, workshops, and presentations at national and international meetings. His main area of research is novel therapies in bleeding disorders in which he has served as Principal Investigator for over 70 international multicentre studies. Prof Mahlangu is current President of the College of Pathologists in South Africa, board member of the South African Medical Research Council, Wits Health Consortium and Poliomyelitis Research Foundation. He is a recipient of more than 15 awards and honors, the most recent of which were the University of the Witwatersrand Vice Chancellor Academic Citizenship Individual Award and the NovoNordisk Foundation International Haemophilia Award in 2018. His past leadership roles include Chair of the Medical and Scientific Advisory Council of the National Haemophilia Foundation of South Africa, President of SA Haematology Society for two non-consecutive terms and Executive member of the World Federation of Haemophilia.

Dr Pravikrishnen Moodley

Dr Pravi Moodley is the Head of the Department of Virology with the National Health Laboratory Service and University of KwaZulu-Natal based at the Inkosi Albert Luthuli Central Hospital in Durban, South Africa. He is a qualified medical doctor with a specialisation and Masters in Virology. He is currently involved in multiple HIV/AIDS Research collaborations internationally and in South Africa. He has co-authored about 35 research papers in peer-reviewed journals. He supervises registrars and teaches undergraduate and postgraduate students in science, medical technology and medicine.


Prof Koleka, Mlisana

Professor Koleka Mlisana, MBChB, MMedPath (Micro), PhD is the Executive Manager: Academic Affairs, Research & Quality Assurance (AARQA) at the National Health Laboratory Service (NHLS). She was until recently the Head of Medical Microbiology at the University of Kwazulu-Natal; previously a co-investigator and Project Director of the CAPRISA 004 tenofovir gel trial at the eThekwini site as well as the Head of HIV Pathogenesis and Vaccine Research Programme at the Centre for the AIDS Program of Research in South Africa (CAPRISA). She has undertaken seminal research which has revealed how the body responds during acute HIV infection. She was the Protocol co-Chair and Project Director of the CAPRISA 002 study, a >10 year follow-up study of patients with acute HIV infection. Her current research interests include TB diagnostics, drug resistance as well as Sexually Transmitted Infections. She has been a member of the Board of the South African Medical Research Council and currently serves on the Ministerial Advisory Committee on Antimicrobial Resistance and is a member of the Board of Trustees for the South African National AIDS Council.

Prof David Rees

Professor David Rees (MBBCH, DOH, MSc{Med}, PhD) is an occupational medicine specialist. He was the Director: National Centre for Occupational Health from 1998 to 2003. He is currently Head of the Division of Occupational Medicine and Epidemiology at the National Institute for Occupational Health, NHLS, and Professor of Occupational Health, School of Public Health, University of the Witwatersrand. Prof Rees has published about 100 peer-reviewed articles.

Prof Rees obtained the following awards in his career: Joan and Ian Webster Gold Medal in Occupational Health (1986), W. Harding le Riche Gold Medal in Epidemiology (1990), Member of Faculty of Occupational Medicine (MFOM), Royal College of Physicians, UK (1997), Faculty of Health Sciences, University of the Witwatersrand, Award for Exceptional Service (2004), and Faculty of Health Sciences, University of the Witwatersrand, recognition for dedication and achievement in research (2015).

Prof Maphoshane Nchabeleng

Professor Maphoshane Nchabeleng obtained her MBChB at the then Natal University. She subsequently obtained the following qualifications: Diploma in Anaesthesiology (CMSA); MMed Microbiology (Natal University); Diploma in HIV management (CMSA; and Postgraduate diploma in Hospital Infection Prevention and Control (Stellenbosch University). As a pathologist she worked at several hospitals including: Natal University / King Edward Hospital Complex – Prince Mshyeni Hospital and Sefako Makgatho Health Sciences University (SMU) / Dr George Mukhari (DGM) Academic Hospital Complex. She is currently the Head of Department of Microbiology and a Pathology representative SMU / DGM Tertiary Laboratory. She is a keen researcher and has established a clinical research unit – MeCRU within the institution as a site principal investigator conducting several large scale trials on HIV prevention strategies including HIV vaccines. Her other areas of interest include Antimicrobial resistance in microorganisms and Hospital Infection Prevention and Control.

Prof Raj Ramesar

Professor Raj Ramesar is the Head of the Division of Human Genetics, and the Department of Pathology at the University of Cape Town (UCT) and its Affiliated Hospitals. Raj is also Director of the South African Medical Research Council (SAMRC) Research Unit for Genomic and Precision Medicine. His group is internationally recognised for their work on the genetics of inherited cancers and Inherited Retinal Degenerative Diseases. They have identified a wide range of new genes and mutations in South African families, and their more recent work is focused on genetic studies in indigenous African communities. Raj has more than 200 publications in international journals and chapters in books, and he serves on the Editorial Board of several international journals
Raj received the (Vice Chancellor’s) Alan Pifer Award for ‘outstanding research in cancer genetics’. In 2016, he was invited to join UCT’s College of Fellows and he was awarded the International Human Genome Organisations (HUGO) Africa Award in Houston, USA. He serves on the board of the Sunflower Fund and is chairman of the Board of the Africa Genome Education Institute. Raj also holds an executive MBA degree from UCT’s Graduate School of Business. His non-academic pursuits include painting in acrylic and watercolours, as well as growing bonsai. .

Prof Jocelyn Naicker

Professor Jocelyn Naicker entered the medical programme at the Nelson Mandela School of Medicine, University of KwaZulu-Natal (UKZN) as a science graduate. After qualifying as a medical doctor, she worked several years in all major medical disciplines (including Paediatrics and Anaesthetics) at King Edward VIII & RK Khan Hospitals. She then moved to Cape Town, where she specialized as a Family Physician. After many years of family medical practice, she moved to Johannesburg at the University of the Witwatersrand (Wits), where she qualified as a Chemical Pathologist. She has worked for the NHLS as a Chemical Pathologist for the past 18 years at various sites including Helen Joseph Hospital & the Gauteng Regional Labs, Chris Hani Baragwanath Academic Hospital, Braamfontein Laboratory Complex and Charlotte Maxeke Johannesburg Academic Hospital. She is currently the Academic Head of the Department of Chemical Pathology, and Head of School of Pathology, at the NHLS Universitas Laboratory Complex, University of the Free State (UFS), Bloemfontein.

Prof Johann Schneider

Professor Johann Schneider (MBChB, MMed (Anat Path), FCPath (SA) is Professor and Head of the Division of Anatomical Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University and National Health Laboratory Service, Tygerberg Academic Hospital, Cape Town, South Africa. He has an interest in dermatopathology, HIV/AIDS-related malignancies, and biobanking. Since 2013, he is the director of the NCI-supported Sub Saharan Africa Regional Biospecimen Repository for the AIDS and Cancer Specimen Resource (ACSR) and the AIDS Malignancy Consortium (AMC). His research interests include HIV-related neoplasia such as Kaposi’s sarcoma, as well as cutaneous tuberculosis, melanoma, and selected inflammatory dermatoses. Current interests also include the ethical-regulatory challenges of biobanking. He is a member of the ACSR Executive Committee and biobank-related working groups.

Prof Tahir Pillay

Professor Tahir Pillay is Professor and Head of the Department of Chemical Pathology and overall Pathology Head, UP and NHLS, Honorary Professor of Chemical Pathology, UCT. He is President of the South African Association for Clinical Biochemistry and Laboratory Medicine. He is Chair of the Communications and Publications Division of the IFCC, the first person from the African continent to head a division of the IFCC since its inception in 1952. He is currently the only full Professor of Chemical Pathology in South Africa and is also NRF-rated.

He is Editor-in-Chief of the Journal of Clinical Pathology. Prof Pillay graduated MBChB cum laude from the University of Natal in the 1980s. He obtained a PhD in biochemistry from the University of Cambridge and completed his postgraduate specialist training at Hammersmith Hospital, Imperial College, London and postdoctoral training in molecular cell biology and endocrinology at the University of California San Diego.

Prof Muriel Meiring

Professor Muriel Meiring is Associate Professor and Principal Scientist in the Department of Haematology and Cell Biology at the University of the Free State (UFS) and National Health Laboratory Service (NHLS). Prof Meiring has established the Specialised Haemostasis Laboratory as a reference center for von Willebrand Disease (VWD) and thrombotic thrombocytopenic purpura (TTP) in South Africa. Through Prof Meiring’s collaboration with Standardization Committees of the International Society on Thrombosis and Haemostasis, the laboratory enjoys international recognition as a reference laboratory. She collaborates with laboratories in Belgium, Hungary and Australia on research regarding haemostasis and on the development of antithrombotic agents and diagnostic kits for haemostatic disorders. She is the inventor of 3 South African and 2 provisional international patents and authored more than 40 peer-reviewed publications. She also heads the Haemostasis and Flow-cytometry Focus Areas of the UFS and chairs the Research and Development Committee of the NHLS.

Prof Clive Gray

Professor Clive Gray is Head and Chair, Division of Immunology in the Department of Pathology and Director of the Laboratory for Tissue Immunology at the NHLS/Groot Schuur Hospital labs. He is a full member at the Institute of Infectious Diseases and Molecular Medicine at UCT and an Adjunct Professor in the Department of Immunology, Duke University, North Carolina, USA. He graduated with an MSc and PhD from the University of the Witwatersrand and was awarded the James Gear Fellowship in 1995 and spent 3 years as a post-doc fellow at Stanford University, Center for AIDS Research. From 1998-2010, he was the head of HIV Immunology at the National Institute for Communicable Diseases, NHLS. In 2004, received the International Leadership Award from the Elizabeth Glaser Pediatric AIDS Foundation, enabling him to start the on-line immunology learning web-site Immunopaedia (www.immunopaedia.org.za), which is now the official International Union of Immunology Societies (IUIS) education on-line learning site. In 2011, he moved to UCT to his current position. He was Chair of the Immunology Expert Committee from 2011-2015 and the overall Chair of the Expert Committees in 2016. He was President of the South African Immunology Society from 2014-2017. He is an NRF B rated scientist with over 100 peer-reviewed publications and is currently the holder of 6 NIH grants. His research interests focus on a) immune regulation and T cell activation within mucosal and epithelial surfaces and the risk of HIV infection and b) immune ontogeny in HIV exposed uninfected newborn infants and how HIV infection on mothers on ARV treatment impacts on fetal-maternal tolerance. He sits on multiple national and international committees and is deeply involved in training Immunology throughout Africa. He will be the co-Chair of the 18th IUIS International Conference on Immunology in 2022, to be held in Cape Town.

Dr Babatyi Malope-Kgokong

Dr Babatyi Innocentia Malope-Kgokong is a National Manager for Academic Affairs and Research (AAR) for the National Health Laboratory Service (NHLS). She is currently the member of the National Health Research Committee (NHRC) appointed by the Minister of Health and the Health Professional Council of South Africa, Committee for Medical Scientists Stakeholders’ representative for the NHLS. She has also served as a member of the Clinical Trials Group Review Task Team and the National Conditional Grants Task Team. Dr Malope-Kgokong has obtained her PhD in Community Health at the University of the Witwatersrand. She has worked in collaboration with the National Cancer Institute, Fredericks; USA and the National Cancer Registry, New South Wales, Sydney in Australia. She has also obtained a Postgraduate Diploma in Economic Policies from the University of London (CeFIMS) and an MSc (Cum Laude) and BSc in Medical Laboratory Sciences majoring in Haematology from the University of Limpopo (UL). She published more than 20 peer-reviewed scientific journal articles as first and co-author. She worked at academic institutions - the UL, University of Johannesburg (UJ) and as an Epidemiologist and Data Manager at the Clinical HIV Research Unit, and the National Institute for Communicable Diseases (NICD).


 

Registration

Open

Already Registered

Open

Abstract Submission

Abstract Submission Guidelines


Important Dates

18 March 2019 Early Bird Registration: opens

07 April 2019 Early Bird Registration: closes

10 May 2019 Standard Registration: closes

05 June 2019 Late registration: closes